SPY366.02+3.96 1.09%
DIA298.44+1.82 0.61%
IXIC12,355.11+156.37 1.28%

VistaGen Therapeutics Q2 EPS $(0.05) Up From $(0.13) YoY

VistaGen Therapeutics (NASDAQ:VTGN) reported quarterly losses of $(0.05) per share. This is a 61.54 percent increase over losses of $(0.13) per share from the same period last year.

· 11/12/2020 17:27
VistaGen Therapeutics (NASDAQ:VTGN) reported quarterly losses of $(0.05) per share. This is a 61.54 percent increase over losses of $(0.13) per share from the same period last year.